AUTL
Autolus Therapeutics
AUTL
AUTL
68 hedge funds and large institutions have $260M invested in Autolus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
19% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 16
6% more funds holding
Funds holding: 64 → 68 (+4)
1.95% more ownership
Funds ownership: 61.22% → 63.17% (+1.9%)
Holders
68
Holding in Top 10
2
Calls
$341K
Puts
$17K
Top Buyers
| 1 | +$21.9M | |
| 2 | +$4.76M | |
| 3 | +$3.78M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$866K |
| 5 |
Two Sigma Investments
New York
|
+$513K |
Top Sellers
| 1 | -$8.14M | |
| 2 | -$5.73M | |
| 3 | -$3.28M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.05M |
| 5 |
Millennium Management
New York
|
-$663K |